Anticoagulation in emergency general surgery: Who bleeds more? The EAST multicenter trials ACES study.
Journal
The journal of trauma and acute care surgery
ISSN: 2163-0763
Titre abrégé: J Trauma Acute Care Surg
Pays: United States
ID NLM: 101570622
Informations de publication
Date de publication:
01 10 2023
01 10 2023
Historique:
medline:
25
9
2023
pubmed:
23
6
2023
entrez:
23
6
2023
Statut:
ppublish
Résumé
While direct oral anticoagulant (DOAC) use is increasing in the Emergency General Surgery (EGS) patient population, our understanding of their bleeding risk in the acute setting remains limited. Therefore, the objective of this study was to determine the prevalence of perioperative bleeding complications in patients using DOACs versus warfarin and AP therapy requiring urgent/emergent EGS procedures (EGSPs). This was a prospective observational trial, conducted between 2019 and 2022, across 21 centers. Inclusion criteria were 18 years or older, DOAC, warfarin/AP use within 24 hours of requiring an urgent/emergent EGSP. Demographics, preoperative, intraoperative, and postoperative data were collected. ANOVA, χ 2 , and multivariable regression models were used to conduct the analysis. Of the 413 patients enrolled in the study, 261 (63%) reported warfarin/AP use and 152 (37%) reported DOAC use. Appendicitis and cholecystitis were the most frequent indication for operative intervention in the warfarin/AP group (43.4% vs. 25%, p = 0.001). Small bowel obstruction/abdominal wall hernias were the main indication for operative intervention in the DOAC group (44.7% vs. 23.8%, p = 0.001). Intraoperative, postoperative, and perioperative bleeding complications and in-hospital mortality were similar between the two groups. After adjusting for confounders, a history of chemotherapy (odds ratio [OR], 4.3; p = 0.015) and indication for operative intervention including occlusive mesenteric ischemia (OR, 4.27; p = 0.016), nonocclusive mesenteric ischemia (OR, 3.13; p = 0.001), and diverticulitis (OR, 3.72; p = 0.019) were associated with increased perioperative bleeding complications. The need for an intraoperative transfusion (OR, 4.87; p < 0.001), and intraoperative vasopressors (OR, 4.35; p = 0.003) were associated with increased in-hospital mortality. Perioperative bleeding complications and mortality are impacted by the indication for EGSPs and patient's severity of illness rather than a history of DOAC or warfarin/AP use. Therefore, perioperative management should be guided by patient physiology and indication for surgery rather than the concern for recent antiplatelet or anticoagulant use. Prognostic and Epidemiologic; Level III.
Sections du résumé
BACKGROUND
While direct oral anticoagulant (DOAC) use is increasing in the Emergency General Surgery (EGS) patient population, our understanding of their bleeding risk in the acute setting remains limited. Therefore, the objective of this study was to determine the prevalence of perioperative bleeding complications in patients using DOACs versus warfarin and AP therapy requiring urgent/emergent EGS procedures (EGSPs).
METHODS
This was a prospective observational trial, conducted between 2019 and 2022, across 21 centers. Inclusion criteria were 18 years or older, DOAC, warfarin/AP use within 24 hours of requiring an urgent/emergent EGSP. Demographics, preoperative, intraoperative, and postoperative data were collected. ANOVA, χ 2 , and multivariable regression models were used to conduct the analysis.
RESULTS
Of the 413 patients enrolled in the study, 261 (63%) reported warfarin/AP use and 152 (37%) reported DOAC use. Appendicitis and cholecystitis were the most frequent indication for operative intervention in the warfarin/AP group (43.4% vs. 25%, p = 0.001). Small bowel obstruction/abdominal wall hernias were the main indication for operative intervention in the DOAC group (44.7% vs. 23.8%, p = 0.001). Intraoperative, postoperative, and perioperative bleeding complications and in-hospital mortality were similar between the two groups. After adjusting for confounders, a history of chemotherapy (odds ratio [OR], 4.3; p = 0.015) and indication for operative intervention including occlusive mesenteric ischemia (OR, 4.27; p = 0.016), nonocclusive mesenteric ischemia (OR, 3.13; p = 0.001), and diverticulitis (OR, 3.72; p = 0.019) were associated with increased perioperative bleeding complications. The need for an intraoperative transfusion (OR, 4.87; p < 0.001), and intraoperative vasopressors (OR, 4.35; p = 0.003) were associated with increased in-hospital mortality.
CONCLUSION
Perioperative bleeding complications and mortality are impacted by the indication for EGSPs and patient's severity of illness rather than a history of DOAC or warfarin/AP use. Therefore, perioperative management should be guided by patient physiology and indication for surgery rather than the concern for recent antiplatelet or anticoagulant use.
LEVEL OF EVIDENCE
Prognostic and Epidemiologic; Level III.
Identifiants
pubmed: 37349868
doi: 10.1097/TA.0000000000004042
pii: 01586154-202310000-00009
doi:
Substances chimiques
Warfarin
5Q7ZVV76EI
Anticoagulants
0
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
510-515Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Lyu HG, Najjar P, Havens JM. Past, present, and future of emergency general surgery in the USA. Acute Med Surg . 2018;5:119–122.
Centers for Disease Control and Prevention. Indicator Definitions - Older Adults. https://www.cdc.gov/cdi/definitions/older-adults.html . Published January 2019. Accessed November 18, 2022.
Hall MJ, Schwartzman A, Zhang J, Liu X. Ambulatory surgery data from hospitals and ambulatory surgery centers: United States, 2010. Natl Health Stat Rep . 2017;102:1–15.
Centers for Disease Control. National Hospital Discharge Survey: Number of All-Listed Procedures for Discharges from Short-Stay Hospitals, by Procedure Category and Age: United States, 2010. www.cdc.gov/nchs/data/nhds/4procedures/2010pro4_numberprocedureage.pdf . Revised November 6, 2015. Accessed August 1, 2021.
LaDuke ZJ, Hecht JP, Cain-Nielsen AH, Hemmila MR, Wahl WL. Association of mortality among trauma patients taking preinjury direct oral anticoagulants versus vitamin K antagonists. Surgery . 2019;166:564–571.
Emigh B, Kobayashi L, Kopp M, Daley M, Teal L, Hann J, et al. The AAST prospective observational multicenter study of the initial experience with reversal of direct oral anticoagulants in trauma patients. Am J Surg . 2021;222:264–269.
Zeeshan M, Jehan F, O’Keeffe T, Khan M, Zakaria E, Hamidi M, et al. The novel oral anticoagulants (NOACs) have worse outcomes compared with warfarin in patients with intracranial hemorrhage after TBI. J Trauma Acute Care Surg . 2018;85:915–920.
Cuker A, Burnett A, Triller D, Crowther M, Ansell J, Van Cott E, et al. Reversal of direct oral anticoagulants: guidance from the anticoagulation forum. Am J Hematol . 2019;94:697–709.
Pollack CV Jr., Reilly P, Van Ryn J, Eikelboom J, Glund S, Bernstein R, et al. Idarucizumab for dabigatran reversal—full cohort analysis. N Engl J Med . 2017;377:431–441.
Connolly S, Crowther M, Eikelboom J, Gibson M, Curnutte J, Lawrence J, et al. Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. N Engl J Med . 2019;380:1326–1335.
Chaudhary R, Singh A, Chaudhary R, Bashline M, Houghton D, Rabinstein A, et al. Evaluation of direct oral anticoagulant reversal agents in intracranial hemorrhage: a systematic review and meta-analysis. JAMA Netw Open . 2022;5:e2240145.
Skaistis J, Tagami T. Risk of fatal bleeding in episodes of major bleeding with new Oral anticoagulants and vitamin K antagonists: a systematic review and meta-analysis. PLoS One . 2015;10:e0137444.
Kobayashi L, Barmparas G, Bosarge P, Brown C, Bukur M, Carrick M, et al. Novel oral anticoagulants and trauma: The results of a prospective American Association for the Surgery of Trauma Multi-Institutional Trial. J Trauma Acute Care Surg . 2017;82:827–835.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform . 2009;42:377–381.
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform . 2019;95:103208.
Cuschieri S. The STROBE guidelines. Saudi J Anaesth . 2019;13:31–S34.
Shafi S, Aboutanos M, Brown CVR, Ciesla D, Cohen M, Crandall M, et al. Measuring anatomic severity of disease in emergency general surgery. J Trauma Acute Care Surg . 2014;76:884–887.
Myers SP, Dadashzadeh ER, Cheung J, Alarcon L, Kutcher M, Brown J, et al. Management of anticoagulation with rivaroxaban in trauma and acute care surgery: complications and reversal strategies as compared to warfarin therapy. J Trauma Acute Care Surg . 2017;82:542–549.
Yee J, Kaide C. Emergency reversal of anticoagulation. West J Emerg Med . 2019;20:770–783.
Garcia D, Crowther M. Reversal of warfarin case-based practice recommendations. Circultaion . 2012;125:2944–2947.
Kustos SA, Fasinu PS. Direct-acting Oral anticoagulants and their reversal agents—an update. Fortschr Med . 2019;6:103.
Zong JH, Eckert L, Zhang L, Dai WS, Cohen AT, Lyman GH. Risk of Major bleeding in Cancer patients receiving chemotherapy. Ann Oncol . 2012;23:ix447.
Scott JW, Olufajo OA, Brat GA, Rose J, Zogg C, Haider A, et al. Use of national burden to define operative emergency general surgery. JAMA Surg . 2016;151:e160480.
Kaafarani H, Kongkaewpaisan N, Aicher B, Diaz JJ Jr., O’Meara LB, Decker C, et al. Prospective validation of the emergency surgery score in emergency general surgery: an Eastern Association for the Surgery of Trauma multicenter study. J Trauma Acute Care Surg . 2020;89:118–124.
Dolmatova EV, Wang K, Mandavilli R, Griendling KK. The effects of sepsis on endothelium and clinical implications. Cardiovasc Res . 2020;117:60–73.
Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez A, et al. OPTIMIS trial study group. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA . 2003;290:238–247.
Levy JH, Connors JM, Steiner ME, Douketis J, Spyropoulos AC. Management of oral anticoagulants prior to emergency surgery or with major bleeding: A survey of perioperative practices in North America: Communication from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis. Res Pract Thromb Haemost . 2020;4:562–568.
Havens J, Peetz A, Do W, Cooper Z, Kelly E, Askari R, et al. The excess morbidity and mortality of emergency general surgery. J Trauma Acute Care Surg . 2015;78:306–311.
Hernandez M, Bruns B, Haddad N, Lauerman M, Morris D, Arnold K, et al. RESHAPES: increasing AAST EGS grade is associated with anastomosis type. J Trauma Acute Care Surg . 2018;84:855–863.